drugset / Trial / NCT06169995
A Study of Remimazolam Tosilate for Sedation in the Upper Gastrointestinal Endoscopy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Remimazolam Tosilate for Injection for sedation in Upper Gastrointestinal Endoscopy
Timeline
- Start
- 2023-12-11
- Primary completion
- 2023-12-15
- Completion
- 2023-12-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Remimazolam | Small molecule | 2.5 mg | Intravenous |
Indications
No indication recorded.